Skip to main content
. 2022 Jun 30;12:899622. doi: 10.3389/fonc.2022.899622

Figure 1.

Figure 1

Prevalence of HCMV-DNA among IBC patients and IHC staining of IBC cancer tissues against CD14, CD68, CD163, and MAC387. (A) Bars represent prevalence of HCMV IgG among IBC patients. (B) Representative agarose gel electrophoresis showing amplicons of HCMV Immediate Early (IE) gene nested PCR (296 bp) among HCMV+ IBC cancer tissues and isolated TME CD14+ monocytes. (C) Scatter plot showing the number of metastatic lymph nodes among HCMV- versus HCMV+ IBC patients. (D) Microscopic images of H and E stained paraffin embedded tissue section of HCMV+ IBC patients showing invasion of cancer cells to lymphatic vessels. (E, F) Microscopic images of CD14 stained paraffin-embedded tissue sections in HCMV- versus HCMV+ IBC cancer tissues and bars showing a significantly high prevalence of CD14+ monocytes among HCMV+ compared to HCMV- IBC cancer tissues. (G, H) Microscopic images of CD14 stained paraffin-embedded tissue sections in HCMV- versus HCMV+ IBC cancer tissues. Bars show no significant difference in the prevalence of CD68+ TAMs among HCMV+ compared to HCMV- IBC cancer tissues. (I, J) Microscopic images of CD163 stained paraffin-embedded tissue sections in HCMV- versus HCMV+ IBC cancer tissues. Bars show a significantly high prevalence of CD163+ TAMs among HCMV+ compared to HCMV- IBC cancer tissues. (K, L) Microscopic images of MAC387 stained paraffin-embedded tissue sections in HCMV- versus HCMV+ IBC cancer tissues and bars showed a significantly high prevalence of MAC387+ TAMs among HCMV+ compared to HCMV- IBC cancer tissues. Data represented the mean of ± SD. P values were calculated using Student t-test, where * represented (P < 0.05).